Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 3/2019

Ausgabe 3/2019

Inhaltsverzeichnis ( 24 Artikel )

18.12.2018 | Original Article | Ausgabe 3/2019 Open Access

Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome

Hirotoshi Iihara, Hironori Fujii, Chiaki Yoshimi, Ryo Kobayashi, Nobuhisa Matsuhashi, Takao Takahashi, Kazuhiro Yoshida, Akio Suzuki

04.12.2018 | Original Article | Ausgabe 3/2019

Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells

Yu Hua Quan, Ji-Young Lim, Byeong Hyeon Choi, Yeonho Choi, Young Ho Choi, Ji-Ho Park, Hyun Koo Kim

08.12.2018 | Original Article | Ausgabe 3/2019 Open Access

A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC

Barbara L. Melosky, Howard John Lim, Janine Marie Davies, Sharlene Gill, Christian K. Kollmannsberger, Maria Yi Ho, Solomon A. Vandt, Daniel John Renouf

06.12.2018 | Original Article | Ausgabe 3/2019

Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205)

Yusuke Suwa, Jun Watanabe, Mitsuyoshi Ota, Shinsuke Suzuki, Hirokazu Suwa, Kazuteru Watanabe, Shuji Saito, Koutaro Nagamine, Masashi Momiyama, Atsushi Ishibe, Yusuke Saigusa, Takeharu Yamanaka, Itaru Endo

03.12.2018 | Original Article | Ausgabe 3/2019

Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report

Matthieu Siebert, Mohammad Alyami, Frederic Mercier, Colin Gallice, Laurent Villeneuve, Frédéric Bérard, Olivier Glehen, Naoual Bakrin, Vahan Kepenekian

01.12.2018 | Original Article | Ausgabe 3/2019

Dose-dense paclitaxel/carboplatin as neo-adjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer: a prospective phase II study

Gabriella Ferrandina, Giacomo Corrado, Giuseppe Vitrano, Valerio Gallotta, Eleonora Palluzzi, Mariagrazia Distefano, Giovanni Scambia

13.12.2018 | Original Article | Ausgabe 3/2019

Low dosage of apatinib monotherapy as rescue treatment in advanced lung squamous cell carcinoma

Da-xiong Zeng, Wei Lei, Chang-guo Wang, Jian-an Huang, Jun-hong Jiang

03.12.2018 | Original Article | Ausgabe 3/2019

A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas

Xuyan Liu, Mingzi Yang, Meng Wu, Wen Zheng, Yan Xie, Jun Zhu, Yuqin Song, Weiping Liu

05.12.2018 | Original Article | Ausgabe 3/2019

Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells

Sadhna Aggarwal, Sarah John, Leena Sapra, Suresh C. Sharma, Satya N. Das

10.12.2018 | Original Article | Ausgabe 3/2019 Open Access

Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study

Naveed Shaik, Brian Hee, Hua Wei, Robert R. LaBadie

08.12.2018 | Original Article | Ausgabe 3/2019

A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer

Linda R. Duska, Gina R. Petroni, Heather Lothamer, William Faust Jr., Jan H. Beumer, Susan M. Christner, Anne M. Mills, Paula M. Fracasso, Sarah J. Parsons

11.12.2018 | Original Article | Ausgabe 3/2019

Evaluation of the effects of an oral notch inhibitor, crenigacestat (LY3039478), on QT interval, and bioavailability studies conducted in healthy subjects

Eunice Yuen, Maria Posada, Claire Smith, Katharine Thorn, Dale Greenwood, Michelle Burgess, Karim A. Benhadji, Demetrio Ortega, Louise Chinchen, Jeffrey Suico

12.12.2018 | Original Article | Ausgabe 3/2019

Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms

Milena Gusella, Felice Pasini, Donatella Caruso, Carmen Barile, Yasmina Modena, Anna Paola Fraccon, Laura Bertolaso, Daniela Menon, Giorgio Crepaldi, Antonio Bononi, Roberto Spezzano, Giorgia Anna Telatin, Giuseppe Corona, Roberto Padrini

08.12.2018 | Original Article | Ausgabe 3/2019

Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer

Sung Yong Oh, Suee Lee, Seok Jae Huh, Jeeyun Lee, Seung Tae Kim, Se Hoon Park, Ho Yeong Lim, Won Ki Kang, Byung Woog Kang, Jong Gwang Kim, Hyo Jin Lee, Jung Hoon Kim, Jung Hun Kang, HoUng Kim

10.12.2018 | Original Article | Ausgabe 3/2019

Pharmacokinetics and bioequivalence of generic and branded abiraterone acetate tablet: a single-dose, open-label, and replicate designed study in healthy Chinese male volunteers

Chunhua Wang, Chaoying Hu, Dan Gao, Zirun Zhao, Xiaoping Chen, Xiao Hu, Shili Gong, Lin Li, Lan Zhang

12.12.2018 | Original Article | Ausgabe 3/2019

Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo

Shudan Wang, Chao Zhang, Yumei Li, Ping Li, Dafang Zhang, Chaoying Li

10.12.2018 | Original Article | Ausgabe 3/2019

Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model

Kate R. Secombe, Imogen A. Ball, Joseph Shirren, Anthony D. Wignall, John Finnie, Dorothy Keefe, Francesca Avogadri-Connors, Elizabeth Olek, David Martin, Susan Moran, Joanne M. Bowen

13.12.2018 | Original Article | Ausgabe 3/2019

Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?

Mahmoud Abu-Amna, Gil Bar-Sela

02.01.2019 | Original Article | Ausgabe 3/2019

Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors

Ravi Paluri, Ankit Madan, Peng Li, Benjamin Jones, Mansoor Saleh, Mary Jerome, Deborah Miley, Jennifer Keef, Francisco Robert

04.01.2019 | Original Article | Ausgabe 3/2019

The value of serum cystatin C in early evaluation of renal insufficiency in patients undergoing chemotherapy: a systematic review and meta-analysis

Liyun He, Jine Li, Jinfeng Zhan, Fengming Yi, Xiude Fan, Yiping Wei, Wenxiong Zhang

05.01.2019 | Original Article | Ausgabe 3/2019

A successful compartmental approach for the treatment of breast cancer brain metastases

Thuy T. Nguyen, Eurydice Angeli, François Darrouzain, Quang T. Nguyen, Céline Desvignes, Marthe Rigal, Osman Nevine, Patrick Nicolas, Quang V. Le, Sabine Winterman, Marie-Christine Pailler, Laurent Zelek, Gilles Paintaud, Anne Janin, Guilhem Bousquet

08.01.2019 | Original Article | Ausgabe 3/2019

Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma

Ken Sasaki, Yasuto Uchikado, Itaru Omoto, Takaaki Arigami, Yusaku Osako, Masahiro Noda, Hiroshi Okumura, Kosei Maemura, Ryutaro Higashi, Takashi Yoshiura, Shoji Natsugoe

08.01.2019 | Original Article | Ausgabe 3/2019

A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity

Mihaela C. Cristea, Paul Frankel, Timothy Synold, Saul Rivkin, Dean Lim, Vincent Chung, Joseph Chao, Mark Wakabayashi, Benjamin Paz, Ernest Han, Paul Lin, Lucille Leong, Amy Hakim, Mary Carroll, Neal Prakash, Thanh Dellinger, Min Park, Robert J. Morgan

08.01.2019 | Short Communication | Ausgabe 3/2019

Inflammatory bowel disease associated with the combination treatment of nivolumab and metformin: data from the FDA adverse event reporting system

Huaqiang Zhou, Jiaqing Liu, Yaxiong Zhang, Li Zhang

Aktuelle Ausgaben


 

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise